Xorte logo

News Markets Groups

USA | Europe | Asia | World| Stocks | Commodities



Add a new RSS channel

 
 


Keywords

2023-05-26 02:15:41| Engadget

Turns out Elon Musk's FDA prediction was only off by about a month. After reportedly denying the company's overtures in March, the FDA approved Neuralink's application to begin human trials of its prototype Link brain-computer interface (BCI) on Thursday. Founded in 2016, Neuralink aims to commercialize BCIs in wide-ranging medical and therapeutic applications from stroke and spinal cord injury (SCI) rehabilitation, to neural prosthetic controls, to the capacity "to rewind memories or download them into robots," Neuralink CEO Elon Musk promised in 2020. BCIs essentially translate the analog electrical impulses of your brain (monitoring it using hair-thin electrodes delicately threaded into that grey matter) into the digital 1's and 0's that computers understand. Since that BCI needs to be surgically installed in a patient's noggin, the FDA which regulates such technologies requires that companies conduct rigorous safety testing before giving its approval for commercial use. In March, the FDA rejected Neuralink's application to begin human trials reportedly in part due to all the test animals that kept dying after having the prototype BCI implanted. According to internal documents acquired by Reuters in December, more than 1,500 animals had been killed in the development of the Neuralink BCI since 2018. The US Department of Agriculture's (USDA) Inspector General has since launched an investigation into those allegations.  The FDA's reticence was also born from concerns about the design and function of the interface when implanted in humans. "The agencys major safety concerns involved the devices lithium battery; the potential for the implants tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue," current and former Neuralink employees told Reuters in March.While Neuralink has obtained FDA approval to begin its study, the company is not yet seeking volunteers. This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," Neuralink Tweeted on Thursday. "Recruitment is not yet open for our clinical trial."  This article originally appeared on Engadget at https://www.engadget.com/neuralink-receives-fda-clearance-to-begin-human-trials-of-its-brain-computer-interface-001504243.html?src=rss


Category: Marketing and Advertising

 

Latest from this category

19.07Schim is an inventive, beautiful platformer that's just a little too repetitive
19.07A nifty hack made Mario a playable character in 1994's Donkey Kong Country
19.07Why an 'unexciting' galaxy could provide clues about the universe's evolution
19.07Samsung Galaxy Z Fold 6 review: The king, but for how much longer?
19.07Google is turning off its goo.gl shortener links next year
19.07The FTC is as mad about the Xbox Game Pass price increase as you are
19.07The Morning After: The age of the retro CD player is here
19.07Faulty cybersecurity update takes out banks, airlines and other major companies worldwide
Marketing and Advertising »

All news

19.07Schim is an inventive, beautiful platformer that's just a little too repetitive
19.07A nifty hack made Mario a playable character in 1994's Donkey Kong Country
19.07Postmasters had fingers in the till, minister told
19.07Italian judge orders a journalist to pay 5,000 euros in damages for making fun of Meloni's height
19.07Why an 'unexciting' galaxy could provide clues about the universe's evolution
19.07Top UN court says Israel's presence in occupied Palestinian territories is illegal and must end
19.07Samsung Galaxy Z Fold 6 review: The king, but for how much longer?
19.07Flights disrupted at OHare and Midway airports amid global technology outage
More »
Privacy policy . Copyright . Contact form .